Morgan Lewis—Tim Powell

Morgan Lewis has welcomed Tim Powell as a partner resident in London. Tim, a co-founder of London-based IP boutique Powell Gilbert, represents clients in high-stakes patent litigation before UK and European courts in the life sciences and technology industries.

Firm chair Jami McKeon said: ‘With significant changes anticipated in the European patent courts and patent assertion throughout the entire EU, our clients require careful, specialised guidance. Tim’s stellar reputation and skilful coordination of complex, cross-border disputes will enhance our global IP practice capabilities in cutting-edge sectors where IP protection is key to our clients’ success.’

Tim helps protect companies from risks related to patent enforcement, regulatory issues, and global IP strategies to ensure they remain competitive and compliant. Tim leverages his complex, multijurisdictional and cross-border patent disputes experience to support clients, particularly biotechnology and pharmaceutical companies, as regulatory entities and courts (specifically the Unified Patent Court) reshape patent enforcement across the EU.

Louis W Beardell, Jr, leader of Morgan Lewis’s global IP practice, said: ‘In recent months, we have strategically added to our European and UK bench, notably with the arrivals of IP litigators Hiroshi Sheraton in London and Drs Alex Klett and Christoph Mikyska in Munich. Tim’s arrival plays a critical role in our overall growth plan.

‘Tim’s presence will immediately enhance the planned expansion of our European/UK team and contribute to the synergies with our already strong IP litigation practice in the United States.’

London office managing partner Nick Bolter added: ‘In a time when biotechnology, pharmaceuticals and other life science technologies are at the centre of innovation, Tim’s representation of clients in some of the most significant recent IP disputes in the United Kingdom and Europe makes him an invaluable addition to our team.